Welcome to

Our platform offers the latest medical news and expert perspectives in IBD;
essential point-of-care drug and disease information;
and relevant professional education.

OUR MISSION

Our mission is to improve medical education with clinical information
and resources essential to physicians
and healthcare professionals.

Who we are

Supporter

Supporter: Janssen Immunology

NEXT APPOINTMENTS

APRIL 12th, 2021
IBDscope
EIM in IBD: looking beyond anti-TNF

APRIL 20th, 2021
IBDscope
CALL TO ACTION: IRON DEFICIENCY ANEMIA MANAGEMENT IN IBD

MAY 3rd, 2021
IBDscope
Positioning drugs in clinical practice: matter of choice

JUNE 14th, 2021
IBDscope
BEST OF DDW: From clinical data to clinical practice

JULY 23rd, 2021
IBDscope
BEST OF ECCO 2021

WEBINARS ON DEMAND

APRIL 1st, 2021
IBDscope

BIOSIMILAR DISPARAGEMENT AND MISINFORMATION THAT ARE AT TIMES FACED BY GASTROENTEROLOGISTS

MARCH 8th, 2021

IBDscope

TRANSMURAL HEALING IN CD: THE ULTIMATE THERAPEUTIC GOAL

MARCH 1st, 2021

IBDforum
Early disease control

FEBRUARY 25th, 2021

IBDscope
OPTIMIZING OUTCOMES IN UC: FROM TRIALS TO PRACTICE

ELDERLY IN IBD

FEBRUARY 22nd, 2021

IBDforum

Biosimilar (anti-TNFs) in IBD

FEBRUARY 18th, 2021

IBDscope
OPTIMIZING OUTCOMES IN UC: FROM TRIALS TO PRACTICE

THROMBOSIS IN UC:
REPORT FROM INTERNATIONAL CONSENSUS

FEBRUARY 15th, 2021
IBDscope
PREVENTION AND MANAGEMENT OF OPPORTUNISTIC INFECTIONS IN IBD DURING THE COVID ERA

FEBRUARY 8th, 2021
IBDscope
Mucosal healing in Ulcerative Colitis

FEBRUARY 4th, 2021

IBDscope

BEST OF 2020

FEBRUARY 1st, 2021

IBDscope
OPTIMIZING OUTCOMES IN UC: FROM TRIALS TO PRACTICE

PREGNANCY IN IBD

JANUARY 11th, 2021
IBDforum
JAK selectivity or GUT selectivity for IBD treatment

NOVEMBER 6nd, 2020

IBDscope
Best of UEG Week Virtual 2020

NOVEMBER 2nd, 2020

IBDforum

Stardust from trial to practice

OCTOBER 27th, 2020

IBDscope
JAKademy – HOW JAK/STAT INHIBITION TRANSLATES IN CLINICS?

OCTOBER 8th, 2020

IBDscope
OPTIMISE MILD-MODERATE UC ACADEMY

OCTOBER 5th, 2020

IBDforum
A new look at treat to target strategies in Crohn’s disease

OCTOBER 1st, 2020
OPTIMISE MILD-MODERATE UC ACADEMY

SEPTEMBER 28th, 2020
OPTIMISE MILD-MODERATE UC ACADEMY

SEPTEMBER 19th, 2020
IBDscope
INFLIXIMAB TREATMENT IN IBD – FROM THEORY TO CLINICAL PRACTICE

SEPTEMBER 15th, 2020
IBDscope
JAKademy – ADDRESSING UNMET NEEDS IN IBD WITH JAK INHIBITION

SEPTEMBER 7th, 2020
IBDforum
GLOBAL IBD FORUM – Disease clearance in UC why and how

JULY 21st, 2020
IBD Practice – on Air
Janssen Virtual Symposium – Dynamic management advancing the management of IBD

JULY 16th, 2020
IBD scope
Early intervention in ulcerative colitis: Ready for prime time?

JULY 9th, 2020
IBD Virtual Preceptorship

JULY 8th, 2020
IBD Virtual Preceptorship

JULY 7th, 2020
IBD Practice – on Air
Celltrion Virtual symposium – Beyond current treatment options in IBD Subcutaneous infliximab

JUNE 16th, 2020
IBD Practice – on Air
Gilead Galapagos Virtual symposium – Evolving treatment in Ulcerative Colitis

JUNE 2nd, 2020
IBD Practice – on Air
AbbVIe Symposium – Weighing the Balance of Steroid Use in IBD – Friend and Foe

MAY 28th, 2020
THE DAY AFTER COVID-19 FOR IBD MANAGEMENT: How to get back to “almost” normality

MAY 25th, 2020
BEST OF DDW: FROM CLINICAL DATA TO CLINICAL PRACTICE

MAY 13th, 2020
COVID-19 and IBD MANAGEMENT

MAY 8th, 2020
IBD MANAGEMENT during COVID-19 outbreak Update

APRIL 30th, 2020
IBD MANAGEMENT during COVID-19 outbreak Update

APRIL 28th, 2020
THE DAY AFTER COVID-19 NELLE IBD

APRIL 28th, 2020
WEBINAR IBD CARE AND COVID-19 – JAPAN

APRIL 27th, 2020
IBD and COVID-19: the invisible enemy

APRIL 21st, 2020
New Insights for COVID-19 and IBD management

APRIL 16th, 2020
PM session h.5:00 PM CEST
IBD AND RHEUMATIC DISEASE TREATMENT AT TIME OF COVID-19 PANDEMIC

APRIL 8th, 2020
AM session
PM session
WHAT IBD SPECIALIST NEEDS TO KNOW ABOUT COVID-19 PANDEMIC

APRIL 1st, 2020
Gestione delle mici durante il covid-19

MARCH 31st, 2020
AM session
PM session
IBD management during COVID-19 outbreak